TD Cowen began coverage of Soleno Therapeutics with a Buy rating on June 27, 2025.
1 report, 0 independent
Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen began coverage of Soleno Therapeutics with a Buy rating on June 27, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Soleno Therapeutics (United States)
company in Redwood City, United States
Nothing else this week.
Related events
- TD Cowen provided analyst ratings and price targets for Werner Enterprises, while Citigroup also lifted its price target based on company performance.
- TD Cowen initiated coverage on Citizens Financial Group shares.
- TD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.
- TD Cowen and Needham & Company provided a buy rating and raised the price objective for Establishment Labs Holdings Inc.
- TD Cowen and Bank of America issued buy ratings and increased price targets on November 2, 2026.
Coverage
Newest first; wire copies grouped- Unknown outlet